"Four FDA-approved drugs decrease overall mortality in humans"

Ahead of his appearance at Longevity Investors Conference, Nir Barzilai talks gerotherapeutics and choosing the right drugs for aging.

Previous
Previous

Cold plunges, red-light therapy. Why some swear by biohacking while others raise concerns

Next
Next

Geroscience luminary, Dr. Nir Barzilai, appointed President of the Academy for Health and Lifespan Research